The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 28,380 585,517 SH   SOLE N/A 585,517 0 0
ALLAKOS INC COM 01671P100 12,839 178,662 SH   SOLE N/A 178,662 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 9,710 1,403,237 SH   SOLE N/A 1,403,237 0 0
AMICUS THERAPEUTICS INC COM 03152W109 22,701 1,505,395 SH   SOLE N/A 1,505,395 0 0
ARGENX SE SPONSORED ADR 04016X101 11,363 50,450 SH   SOLE N/A 50,450 0 0
AXSOME THERAPEUTICS INC COM 05464T104 17,781 216,098 SH   SOLE N/A 216,098 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 8,533 169,949 SH   SOLE N/A 169,949 0 0
INSMED INC COM PAR $.01 457669307 27,837 1,010,797 SH   SOLE N/A 1,010,797 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 16,577 603,890 SH   SOLE N/A 603,890 0 0
KARYOPHARM THERAPEUTICS INC COM 48576U106 12,356 652,351 SH   SOLE N/A 652,351 0 0
KINIKSA PHARMACEUTICALS LTD COM CL A G5269C101 5,099 200,125 SH   SOLE N/A 200,125 0 0
NEOLEUKIN THERAPEUTICS INC COM 64049K104 12,783 770,073 SH   SOLE N/A 770,073 0 0
TRILLIUM THERAPEUTICS INC COM NEW 89620X506 11,999 1,483,181 SH   SOLE N/A 1,483,181 0 0
ZOGENIX INC COM NEW 98978L204 26,250 971,875 SH   SOLE N/A 971,875 0 0